The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

CDI Corporation

Related Interviews

Bottom-Up Investing with an Absolute-Value Focus
November 11, 2013

LIFE SCIENCE TOOL COMPANIES: JOHN SULLIVAN - LEERINK SWANN & CO
July 25, 2005

EMPLOYER SERVICES: MARK MARCON - WACHOVIA SECURITIES
September 13, 2004

OUTLOOK FOR INTERNET MEDIA COMPANIES: MARK MAY - KAUFMAN BROTHERS LP
September 08, 2004

CREDIT CARD PROCESSORS & E-PAYMENT: WAYNE JOHNSON - SUNTRUST ROBINSON HUMPHREY CAPITAL MARKETS
May 25, 2004

Outlook For Temporary Help Companies: Andrew Steinerman - Bear, Stearns & Co
October 06, 2003

Outlook For Gaming & Gaming Equipment: Jason Ader - Bear, Stearns & Co
November 25, 2002

Oil Services Stocks: Arving Sanger - Deutsche Bank Securities Inc
August 12, 2002

Healthcare Facilities: Ken Weakley - Ubs Warburg
February 02, 2002

Joseph Looney - Manchester Technologies Inc (manc)
January 28, 2002

Pc, Server & Storage Companies: David Bailey - Gerard Klauer Mattison & Co
January 28, 2002

Support Services In Europe: Andrew Sweeting / Konrad Zomer - Credit Suisse First Boston
March 21, 2001

Outlook For Networking: Christopher Stix - Morgan Stanley Dean Witter
March 19, 2001

Long-term Care Stocks: Howard Capek - Ubs Warburg
November 27, 2000

Christopher J. Ainley - Trust Company Of The West
February 14, 2000

Cart

Latest News

The Robots from this Company Will Build You a New Spine
Lord Abbett Portfolio Manager Reveals the Process for Picking Winning Innovative Growth Stocks
Fundamental Analysis on Small Cap Stocks: Value Upside Returns

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)

Robert Fried

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: NAGE

Buy ($25)

Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)

Steven Lo

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: VXRT

Buy ($25)

Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)

Frank Bedu-Addo

Published March 02, 2026 in Biotechnology and Pharmaceuticals

Companies covered: PDSB

Buy ($25)

Most Popular Reports

Biotechnology and Pharmaceuticals

Published March 02, 2026

Topics covered: Biotechnology and Pharmaceuticals

Buy ($175)

Medical Devices and Life Science Tools

Published February 23, 2026

Topics covered: Medical Devices and Life Science Tools

Buy ($175)

Investing Strategies: Micro, Small and Smid Cap

Published February 05, 2026

Topics covered: Micro, Small and Smid Cap

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)
Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Supply Constraints Translate Into Pricing Power for Eagle Materials
Share Price Pullback Creates Attractive Entry Point for Urban Outfitters
VSE Corp: A Play on Strong Aerospace Aftermarket Demand
ANALYST INTERVIEWS
Argenx Builds Momentum on Strong Execution and Expanding Indications
Omeros Tackles Lethal Transplant Risks with First-in-Class Therapy
Uptick in M&A Among Tailwinds Boosting Biotech Sector
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google